Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                FDA’s Labeling Resources for Human Prescription Drugs

FDA’s Labeling Resources for Human Prescription Drugs

                        Prescribing Information Resources
          Patient Labeling Resources
          Carton and Container Labeling Resources
          Selection of Appropriate SPL Codes for Human Prescription Drug Labeling
          Generic Drugs - Specific Labeling Resources
          Biological Products - Specific Labeling Resources
          Frequently Asked Questions about Labeling for Prescription Medicines
          Prescription Drug Labeling Contact Information Home
          Drugs
          Guidance, Compliance, & Regulatory Information
          Laws, Acts, and Rules
          FDA’s Labeling Resources for Human Prescription Drugs
          Carton and Container Labeling ResourcesFDA’s Labeling Resources for Human Prescription Drugs Carton and Container Labeling Resources
  
  					For Industry
	
    Share
    Post
    Linkedin

    Email
    PrintOn this webpage

Who Is the Audience for This Website?
	General Carton and Container Labeling Statutory/Regulatory Provisions
	Specific Container Label Statement Requirements
	Carton and Container Labeling Guidances and MAPPs
	Other Carton and Container Labeling Resources
	Example Container Label
	Contact Information


Who Is the Audience for This Website?

FDA’s carton and container labeling specific resources on this webpage are primarily directed to industry staff who develop carton and container labeling for prescription drugs.* For other prescription drug labeling resources for industry such as those for the Prescribing Information, FDA-approved patient labeling, generic drug labeling, biological product labeling, labeling databases, and product databases visit FDA’s Labeling Resources for Human Prescription Drugs. If you are a healthcare professional, patient, or caregiver, visit Frequently Asked Questions about Labeling for Prescription Medicines.

General Carton and Container Labeling Statutory/Regulatory Provisions

Section 201(k) and (m) of FD&C Act: Statutory definition of “label” and “labeling”, respectively.
	21 CFR 201.100(b): Prescription label requirements
	21 CFR 201.10(i): Small label requirements
	21 CFR 201.6: Misleading statement
	21 CFR 201.15: Prominence of required label statements
	21 CFR 610.60: Container label for biological products
	21 CFR 610.61:  Package labeling for biological products
	21 CFR 610.62: Proper name; package label; legible type
	21 CFR 610.63: Divided manufacturing responsibility to be shown
	21 CFR 610.64: Name and address of distributorSpecific Container Label Statement Requirements

21 CFR 201.50: Statement of identity (established name)
	21 CFR 201.51: Declaration of net quantity of contents
	21 CFR 201.55: Statement of dosage (e.g., Recommended Dosage: see Prescribing Information)
	21 CFR 201.10: Statement of ingredients (active and inactive)
	21 CFR 201.17: Location of expiration date
	21 CFR 201.18: Significance of control numbers (Lot number)
	21 CFR 201.1: Name and place of business of manufacturer, packer, or distributor
	21 CFR 201.2: National Drug Code (NDC)
	21 CFR 201.15: Prominence of required label statements
	21 CFR 201.20(a): FD&C Yellow No. 5
	21 CFR 201.25:  Bar code label requirementsCarton and Container Labeling Guidances and MAPPs

Allowable Excess Volume and Labeled Vial Fill Size in Injectable Drug and Biological Products (final guidance)
	Bar Code Label Requirements Questions and Answers (final guidance)
	Best Practices in Development Proprietary Names for Human Prescription Drug Products (final guidance)
	CDER Barcode Inquiries MAPP
	Child-Resistant Packaging Statements in Drug Product Labeling (final guidance)
	Gluten in Drug Products and Associated Labeling Recommendations (draft guidance)
	Harmonizing Compendial Standards With Drug Application Approval Using the USP Pending Monograph Process (draft guidance)
	Incorporation of Physical-Chemical Identifiers into Solid Oral Dosage Form Drug Products for Anticounterfeiting (final guidance)
	Liposome Drug Products: CMC; Human PK and Bioavailability; and Labeling Documentation (final guidance)
	Metered Dose Inhaler and Dry Powder Inhaler Drug Products - Quality Considerations (draft guidance)
	Naming of Drug Products Containing Salt Drug Substances (final guidance and MAPP)
	Product Identifiers Under the Drug Supply Chain Security Act Questions and Answers (final guidance) and Product Identifier Requirements Under the Drug Supply Chain Security Act – Compliance Policy (final guidance)
	Quality Attribute Considerations for Chewable Tablets (final guidance)
	Recommendations for Labeling Medical Products to Inform Users that the Product or Product Container is not Made with Natural Rubber Latex (final guidance)
	Safety Considerations for Container Labels and Carton Labeling Design to Minimize Medication Errors (final guidance)
	Safety Considerations for Product Design to Minimize Medication Errors (final guidance)
	Selection of the Appropriate Package Type Terms and Recommendations for Labeling Injectable Medical Products Packaged in Multiple-Dose, Single-Dose, and Single-Patient-Use Containers for Human Use (final guidance)
	Transdermal and Topical Delivery Systems - Product Development and Quality Considerations (draft guidance)Other Carton and Container Labeling Resources

Drug Product Nomenclature (2019 presentation and video)
	FDA List of Established Drug Names Recommended to Use Tall Man Lettering
	Improving Consistency of Information Between Carton-Container Labeling and Prescribing Information (2019 presentation and video)
	Institute for Safe Medication Practices’ List of Error-Prone Abbreviations, Symbols, and Dose Designations
	Safety Considerations for Container Labels and Carton Labeling Design to Minimize Medication Errors (2019 presentation, and 2019 video)
	United States Pharmacopeia Resources (these resources require a USP subscription):
	Chapter <7> (Labeling) provides definitions and labeling standards for official USP articles including strength expression for injectable products, pharmacy bulk packages, imaging bulk packages, labeling for ferrules and cap overseals, aluminum use in parenteral nutrition, and expiration and beyond the use date.
		Chapter <659> (Packaging and Storage Requirements) provides definitions for packaging, package type terms for injectable medical products, noninjectable packaging containers, measuring devices (e.g., dosing cup, dosing spoon, medicine dropper, oral syringe), temperature, and storage
		Chapter <1091> (Labeling of Inactive Ingredients) provides guidelines for labeling of inactive ingredients to help promote consistency in labeling.
		Chapter <1121> (Nomenclature) provides general practices for drug product nomenclature.Example Container Label

example container label




Contact Information

For specific application or supplement questions or for general questions about prescription drug labeling, please visit Prescribing Drug Labeling Contact Information.

                                                                                  Content current as of:
      08/08/2022
              
              
Regulated Product(s)
		 DrugsFDA’s Labeling Resources for Human Prescription Drugs

          
                        Prescribing Information Resources
          Patient Labeling Resources
          Carton and Container Labeling Resources
          Selection of Appropriate SPL Codes for Human Prescription Drug Labeling
          Generic Drugs - Specific Labeling Resources
          Biological Products - Specific Labeling Resources
          Frequently Asked Questions about Labeling for Prescription Medicines
          Prescription Drug Labeling Contact Information
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop